Controlling the Outcome of the Toll-Like Receptor Signaling Pathways

被引:4
作者
Richard, Guilhem [1 ]
Belta, Calin [1 ]
Julius, A. Agung [2 ]
Amar, Salomon [1 ,3 ]
机构
[1] Boston Univ, Program Bioinformat, Boston, MA 02215 USA
[2] Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY USA
[3] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA
基金
美国国家科学基金会;
关键词
NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; MODELS; FAMILY;
D O I
10.1371/journal.pone.0031341
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Toll-Like Receptors (TLRs) are proteins involved in the immune system that increase cytokine levels when triggered. While cytokines coordinate the response to infection, they appear to be detrimental to the host when reaching too high levels. Several studies have shown that the deletion of specific TLRs was beneficial for the host, as cytokine levels were decreased consequently. It is not clear, however, how targeting other components of the TLR pathways can improve the responses to infections. We applied the concept of Minimal Cut Sets (MCS) to the ihsTLR v1.0 model of the TLR pathways to determine sets of reactions whose knockouts disrupt these pathways. We decomposed the TLR network into 34 modules and determined signatures for each MCS, i.e. the list of targeted modules. We uncovered 2,669 MCS organized in 68 signatures. Very few MCS targeted directly the TLRs, indicating that they may not be efficient targets for controlling these pathways. We mapped the species of the TLR network to genes in human and mouse, and determined more than 10,000 Essential Gene Sets (EGS). Each EGS provides genes whose deletion suppresses the network's outputs.
引用
收藏
页数:9
相关论文
共 35 条
[1]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[2]   Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli [J].
Covert, Markus W. ;
Xiao, Nan ;
Chen, Tiffany J. ;
Karr, Jonathan R. .
BIOINFORMATICS, 2008, 24 (18) :2044-2050
[3]   A computational framework for the topological analysis and targeted disruption of signal transduction networks [J].
Dasika, Madhukar S. ;
Burgard, Anthony ;
Maranas, Costas D. .
BIOPHYSICAL JOURNAL, 2006, 91 (01) :382-398
[4]   Toll-like receptors: From the discovery of NFKB to new insights into transcriptional regulations in innate immunity [J].
Doyle, Sarah L. ;
O'Neill, Luke A. J. .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (09) :1102-1113
[5]   In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data [J].
Edwards, JS ;
Ibarra, RU ;
Palsson, BO .
NATURE BIOTECHNOLOGY, 2001, 19 (02) :125-130
[6]   A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information [J].
Feist, Adam M. ;
Henry, Christopher S. ;
Reed, Jennifer L. ;
Krummenacker, Markus ;
Joyce, Andrew R. ;
Karp, Peter D. ;
Broadbelt, Linda J. ;
Hatzimanikatis, Vassily ;
Palsson, Bernhard O. .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3
[7]   The Rel/NF-κB signal transduction pathway:: introduction [J].
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6842-6844
[8]   TLR3 deletion limits mortality and disease severity due to phlebovirus infection [J].
Gowen, Brian B. ;
Hoopes, Justin D. ;
Wong, Min-Hui ;
Jung, Kie-Hoon ;
Isakson, Kevin C. ;
Alexopoulou, Lena ;
Flavell, Richard A. ;
Sidwell, Robert W. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (09) :6301-6307
[9]  
Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469
[10]   Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88 [J].
Hasan, U ;
Chaffois, C ;
Gaillard, C ;
Saulnier, V ;
Merck, E ;
Tancredi, S ;
Guiet, C ;
Brière, F ;
Vlach, J ;
Lebecque, S ;
Trinchieri, G ;
Bates, EEM .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2942-2950